Retatrutide is an experimental triple hormone receptor agonist currently being studied for its effects on weight loss, type 2 diabetes, and metabolic health. It activates GLP-1, GIP, and glucagon receptors—key pathways that regulate appetite, blood glucose, and energy balance.
All products sold on our website are intended solely for in vitro testing and laboratory research purposes only. Products are supplied as lyophilized powder in sterile, sealed vials and require reconstitution prior to use. Each vial is clearly labeled. Additional laboratory equipment is required.




